Suarez, Catherine L.
HRN: 23-90-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2023
CEFUROXIME 1.5GM (VIAL)
10/30/2023
10/30/2023
IVT
1.5g
On Call To OR ANST
AUB Rule Out Endometrial Pathology; Bilateral ONG; Hypertension Stage II; G2P1 (1010)
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes